Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
15 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-reports-first-quarter-2025-financials-1028085
06 Feb 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filame-980424
07 Jan 2025
// ACCESSWIRE
https://www.accesswire.com/964484/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-to-present-january-12-at-the-annual-neuroscience-innovation-forum
10 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/924759/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-to-present-october-16-at-bio-investor-forum
15 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/15/2781064/0/en/PharmAla-Biotech-and-Filament-Health-Announce-Release-of-Second-Batch-of-GMP-MDMA-Capsules.html
16 Mar 2023
// NEWSWIRE
https://www.newswire.ca/news-releases/filament-health-announces-fda-approval-of-phase-ii-clinical-trial-studying-psilocybin-for-methamphetamine-use-disorder-801405766.html
ABOUT THIS PAGE
Filament Health is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Psilocin bulk with DMF offered by Filament Health
Find a price of Psilocybine bulk with DMF offered by Filament Health